The price of Clostridium perfringens type A toxoid seems high. How can I justify this investment?
The cost of NE in either its clinical or subclinical forms far exceeds the investment in vaccinating breeder flocks with Clostridium perfringens type A toxoid. It has been estimated by industry experts that NE costs on average $0.05 per bird, which is more than 10 times greater than the cost of vaccination. In field trials conducted in the United States by Schering-Plough Animal Health, improvement in livability and reduced production costs among flocks that received Clostridium perfringens type A toxoid at three large-bird complexes resulted in an estimated return on investment of 8:1.
Related Questions
- If I vaccinate my pullet flocks with Clostridium perfringens type A toxoid, do I still need to use water acidifiers, probiotics, enzymes and prebiotics to keep my antibiotic-free flocks free from NE?
- Can I use Clostridium perfringens type A toxoid to help protect broiler flocks that will be medicated with a full level of in-feed antibiotic growth promoters?
- The price of Clostridium perfringens type A toxoid seems high. How can I justify this investment?
